---
run_id: halo-evidence-vs-diagnosis-validation-v10-criteria-prompted-no-sources-01
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v10
benchmark_version: halo-evidence-vs-diagnosis-validation-v10-v1
model_condition: criteria_prompted_no_sources
run_number: 1
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 106
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: 99e91b34c6105209d4266fed0bcb0ab798bcedfae3a4ab5516c3c91fc972adaa
condition_packet_sha256: 99e91b34c6105209d4266fed0bcb0ab798bcedfae3a4ab5516c3c91fc972adaa
output_file: model-outputs/criteria_prompted_no_sources.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 01)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v10-v1`, condition `criteria_prompted_no_sources`, run 1 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 106, on the frozen condition packet.

## Output

**Recommendation**

Commit to the Claim File Review.

**Reasoning**

The current success signals are heavily contaminated by financial incentives and behavioral biases. The rise in expansion bookings is tied to temporary pricing bundles rather than perceived value, and the positive customer feedback was solicited after sales teams promised a specific future roadmap. Furthermore, usage metrics are inflated by managers performing retrospective audits rather than adjusters using the tool for live production.

The Usage Quality Sprint would likely hide failure by focusing on "cleaner enablement," which risks misinterpreting a lack of tool utility as a training deficiency. The Commercial Cleanroom would test sales tactics and pricing elasticity, but it cannot tell you if the product actually works. Only the Claim File Review provides independent evidence by examining the actual output (the claim file) rather than self-reported sentiment or surface-level click rates. It directly addresses the critical failure point in regulated segments—the inability to explain a recommendation—by forcing reviewers to categorize overrides and rewrites.

**Strongest Reason Against**

This approach ignores the immediate commercial momentum. By choosing a diagnostic review over scaling or sales testing, you risk stalling the current expansion streak and potentially alienating a sales force that is currently winning deals based on the DraftPath narrative.

**Observable Evidence to Change Recommendation**

If you discover that the "overridden" or "impossible to explain" rate in the Claim File Review is below 10% across all segments, it would indicate that the product's core logic is sound and the friction is purely a matter of user habit or training. In that case, I would shift the recommendation to scaling DraftPath broadly.
